Role of Individualised Homoeopathic Medicine in cases of Dementia in the age group of 50-80 years based on Kent’s Repertory: An Open Label Observational Clinical Study
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- To observe the change in the score of Montreal Cognitive Assessment (MoCA) over 6 months from baseline
研究概览
简要总结
-
A minimum 40 samples would be chosen in this study suffering from Dementia.
-
Case taking of patients will be done as per standardized case recording proforma of National Institute of Homoeopathy, Kolkata.
-
Each case will be studied properly through evaluation of each and every symptom, and construction of a qualitative totality of symptoms.
-
Patients will receive individualised homoeopathic medicine after repertorisation from Kent’s Repertory.
-
Relevant investigations will be done as and when required.
-
Inclusion and exclusion criteria will be strictly maintained.
-
Each case will be assessed periodically to follow up the medicinal action through clinical assessment, expert opinion and relevant lab investigations.
-
Change in MoCA test will be recorded at base-line and after 6-months of the treatment
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 50.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients having symptoms of dementia.
- •Patient willing to participate in the study after submitting their written informed consent forms.
- •Patient of both gender and all religion.
- •Patient belonging to age group of 50 to 80 years.
- •Patient must know either of the 3 languages- Bengali, Hindi or English.
- •Lifesaving conventional drug therapies (e.g., antidiabetics, antihypertensives, thyroid drugs, etc.) for comorbidities under control, to be continued uninterrupted.
排除标准
- •Currently receiving homoeopathic treatment for any chronic condition(s).
- •Diagnosed cases of unstable mental or psychiatric illness or other systemic disease affecting quality of life.
- •Uncontrolled, unevaluated, and/or complicated diabetes mellitus, hypertension, and other comorbidities; cases with other serious systemic unevaluated or uncontrolled diseases affecting quality of life.
- •Substance abuse and/or dependence.
- •Self-reported immune-compromised state.
结局指标
主要结局
To observe the change in the score of Montreal Cognitive Assessment (MoCA) over 6 months from baseline
时间窗: Baseline and after 6 months
次要结局
未报告次要终点
研究者
Dr Rajdeep Saha
National Institute of Homoeopathy